益安生醫股份有限公司
益安生醫股份有限公司（Medeon Biodesign, Inc.）為微創手術器材之研發與授權商。核心業務為開發具備高門檻技術的二類或三類醫療器材，如大口徑血管縫合器（Cross-Seal）、前列腺肥大手術器械及骨科微創耗材。公司採取「研發、臨床試驗後進行國際大廠授權」的經營模式。公司成立於 2012 年，總部位於台灣台北市。
今日上漲 4.35%，股價站回短期均線。該股 RSI(6) 為 53.9，處於中性區間，短線無明顯超買超賣訊號。股價站上5日均線，跌破20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=38.2）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +129 | 0 | 0 | +129 |
| 08-07 | +1 | 0 | +4 | +1 |
| 08-06 | -30 | 0 | +2 | -30 |
| 08-05 | -58 | 0 | 0 | -58 |
| 08-04 | +134 | 0 | 0 | +134 |
| 08-03 | +10 | 0 | +2 | +10 |
| 07-31 | +3 | 0 | 0 | +3 |
| 07-30 | +95 | 0 | +4 | +96 |
| 07-29 | +335 | 0 | +2 | +334 |
| 07-28 | +61 | 0 | +2 | +62 |
| 07-27 | +37 | 0 | +2 | +37 |
| 07-24 | +12 | 0 | 0 | +12 |
| 07-23 | -6 | 0 | +2 | -6 |
| 07-22 | -18 | 0 | +2 | -18 |
| 07-21 | -23 | 0 | 0 | -23 |
| 07-20 | +216 | 0 | 0 | +216 |
| 07-17 | +2 | 0 | 0 | +2 |
| 07-16 | -10 | 0 | 0 | -10 |
| 07-15 | -9 | 0 | 0 | -9 |
| 07-14 | +46 | 0 | +14 | +47 |
| 07-13 | +9 | 0 | +2 | +9 |
| 07-09 | +25 | 0 | 0 | +25 |
| 07-08 | -72 | 0 | +4 | -73 |
| 07-07 | +62 | 0 | +2 | +62 |
| 07-06 | +30 | 0 | +2 | +30 |
| 07-03 | +15 | 0 | +2 | +15 |
| 07-02 | -19 | 0 | 0 | -19 |
| 07-01 | +10 | 0 | +4 | +10 |
| 06-30 | -40 | 0 | +4 | -40 |
| 06-29 | -12 | 0 | +14 | -13 |
| 06-26 | -79 | 0 | +13 | -79 |
| 06-25 | -27 | 0 | +6 | -28 |
| 06-24 | +4 | 0 | 0 | +4 |
| 06-23 | +46 | 0 | +1 | +46 |
| 06-22 | -33 | 0 | +6 | -33 |
| 06-18 | +44 | 0 | +2 | +44 |
| 06-17 | -118 | 0 | +7 | -117 |
| 06-16 | -88 | 0 | +4 | -88 |
| 06-15 | -5 | 0 | +2 | -4 |
| 06-12 | -40 | 0 | 0 | -41 |
| 06-11 | -7 | 0 | +10 | -6 |
| 06-10 | -38 | 0 | +10 | -38 |
| 06-09 | -51 | 0 | +4 | -51 |
| 06-08 | +45 | 0 | +8 | +45 |
| 06-05 | -5 | 0 | +12 | -79 |
| 06-04 | +35 | 0 | +2 | -41 |
| 06-03 | -71 | 0 | +2 | -71 |
| 06-02 | -143 | 0 | +34 | -143 |
| 06-01 | -70 | 0 | +8 | -69 |
| 05-29 | -87 | 0 | 0 | -87 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 3714 萬 | +2.8% | +3.4% |
| 2026/03 | 3611 萬 | -24.6% | -6.7% |
| 2026/02 | 4791 萬 | +58.3% | +32.3% |
| 2026/01 | 3027 萬 | -16.5% | +12.3% |
| 2025/12 | 3624 萬 | -13.0% | +49.6% |
| 2025/11 | 4167 萬 | +12.7% | +69.1% |
| 2025/10 | 3697 萬 | -2.1% | +29.8% |
| 2025/09 | 3776 萬 | +28.5% | +58.4% |
| 2025/08 | 2940 萬 | +16.9% | -53.6% |
| 2025/07 | 2514 萬 | -35.9% | +42.5% |
| 2025/06 | 3925 萬 | +11.4% | +77.6% |
| 2025/05 | 3522 萬 | - | +70.2% |